Add to cart
A Clinically-validated Advanced Regenerative Technology Targeting the Causes of Underlying Conditions
When dealing with disturbing health problems, like fibromyalgia, varicose veins, chronic wounds, or reduced athletic endurance, D’OXYVA® is the non-invasive regenerative technology you can trust.
Based on over three dozen exceptionally successful human studies, D’OXYVA delivers consistent and powerful results in 4-8 weeks based on Nobel Prize-winning scientific advances.
Groundbreaking pivotal clinical evidence is being expanded by world-class medical scientists and doctors to eighteen of the twenty top-ranked medical universities including, UCLA, MIT, Yale, Harvard, Northwestern, Drexel, and others.
Rest assured you are in good hands with an established decade-long record of zero adverse event reports and hundreds of thousands of successful applications in over three dozen countries. Please let us know what you think.
Papers included in this eBook:
- General Patient Overview
- ANS Dysfunction as a Fibromyalgia Cause
- Impaired Tissue Perfusion – A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus (American Heart Association)
- Transdermal CO2 Increases Perfusion Index in Patients with Placenta Accreta Following Temporary Abdominal Aortic Cross-Clamping
- Prof. Judy Delp PhD – Transdermal CO2 Microcirculation
